Metastatic Sarcoma Completed Phase 1 Trials for Bevacizumab (DB00112)
Also known as: Sarcoma metastatic / Metastatic sarcoma (disorder) / Sarcoma, metastatic (morphologic abnormality)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0047219 (Metastatic Sarcoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01106872 | Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas | Treatment |